Cargando…

Potent neutralizing nanobodies resist convergent circulating variants of SARS-CoV-2 by targeting diverse and conserved epitopes

Interventions against variants of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) are urgently needed. Stable and potent nanobodies (Nbs) that target the receptor binding domain (RBD) of SARS-CoV-2 spike are promising therapeutics. However, it is unknown if Nbs broadly neutralize circul...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sun, Dapeng, Sang, Zhe, Kim, Yong Joon, Xiang, Yufei, Cohen, Tomer, Belford, Anna K., Huet, Alexis, Conway, James F., Sun, Ji, Taylor, Derek J., Schneidman-Duhovny, Dina, Zhang, Cheng, Huang, Wei, Shi, Yi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8333356/ https://www.ncbi.nlm.nih.gov/pubmed/34344900 http://dx.doi.org/10.1038/s41467-021-24963-3

Ejemplares similares

Potent neutralizing nanobodies resist convergent circulating variants of SARS-CoV-2 by targeting novel and conserved epitopes
por: Sun, Dapeng, et al.
Publicado: (2021)

NanoNet: Rapid and accurate end-to-end nanobody modeling by deep learning
por: Cohen, Tomer, et al.
Publicado: (2022)

Versatile and multivalent nanobodies efficiently neutralize SARS-CoV-2
por: Xiang, Yufei, et al.
Publicado: (2020)

Versatile, Multivalent Nanobody Cocktails Efficiently Neutralize SARS-CoV-2
por: Xiang, Yufei, et al.
Publicado: (2020)

Superimmunity by pan-sarbecovirus nanobodies
por: Xiang, Yufei, et al.
Publicado: (2022)

A nanobody recognizes a unique conserved epitope and potently neutralizes SARS-CoV-2 omicron variants
por: Modhiran, Naphak, et al.
Publicado: (2023)

A resource of high-quality and versatile nanobodies for drug delivery
por: Shen, Zhuolun, et al.
Publicado: (2021)

Predicting structures of large protein assemblies using combinatorial assembly algorithm and AlphaFold2
por: Shor, Ben, et al.
Publicado: (2023)

Development of potent and effective synthetic SARS-CoV-2 neutralizing nanobodies
por: Stefan, Maxwell A., et al.
Publicado: (2021)

FoXS: a web server for rapid computation and fitting of SAXS profiles
por: Schneidman-Duhovny, Dina, et al.
Publicado: (2010)

The SARS-CoV-2 Exerts a Distinctive Strategy for Interacting with the ACE2 Human Receptor
por: Brielle, Esther S., et al.
Publicado: (2020)

Nanobodies targeting norovirus capsid reveal functional epitopes and potential mechanisms of neutralization
por: Koromyslova, Anna D., et al.
Publicado: (2017)

Integrative structural modeling with small angle X-ray scattering profiles
por: Schneidman-Duhovny, Dina, et al.
Publicado: (2012)

Nanobodies that Neutralize HIV
por: Weiss, Robin A., et al.
Publicado: (2019)

Accelerating PERx reaction enables covalent nanobodies for potent neutralization of SARS-CoV-2 and variants
por: Yu, Bingchen, et al.
Publicado: (2022)

Development of humanized tri-specific nanobodies with potent neutralization for SARS-CoV-2
por: Dong, Jianbo, et al.
Publicado: (2020)

Neutralization of SARS‐CoV‐2 by highly potent, hyperthermostable, and mutation‐tolerant nanobodies
por: Güttler, Thomas, et al.
Publicado: (2021)

A potent alpaca-derived nanobody that neutralizes SARS-CoV-2 variants
por: Weinstein, Jules B., et al.
Publicado: (2022)

Reduced antigenicity of Omicron lowers host serologic response
por: Tubiana, Jérôme, et al.
Publicado: (2022)

Reduced B cell antigenicity of Omicron lowers host serologic response
por: Tubiana, Jérôme, et al.
Publicado: (2022)

A broadly neutralizing nanobody targeting the highly conserved S2 subunit of sarbecoviruses
por: Wang, Xiaoyun, et al.
Publicado: (2023)

PatchDock and SymmDock: servers for rigid and symmetric docking
por: Schneidman-Duhovny, Dina, et al.
Publicado: (2005)

FoXS, FoXSDock and MultiFoXS: Single-state and multi-state structural modeling of proteins and their complexes based on SAXS profiles
por: Schneidman-Duhovny, Dina, et al.
Publicado: (2016)

A potent neutralizing nanobody against SARS‐CoV‐2 with inhaled delivery potential
por: Gai, Junwei, et al.
Publicado: (2021)

Shark nanobodies with potent SARS-CoV-2 neutralizing activity and broad sarbecovirus reactivity
por: Chen, Wei-Hung, et al.
Publicado: (2023)

Predicting CD4 T-cell epitopes based on antigen cleavage, MHCII presentation, and TCR recognition
por: Schneidman-Duhovny, Dina, et al.
Publicado: (2018)

An ultra-potent synthetic nanobody neutralizes SARS-CoV-2 by locking Spike into an inactive conformation
por: Schoof, Michael, et al.
Publicado: (2020)

Neutralizing and Enhancing Epitopes of the SARS-CoV-2 Receptor-Binding Domain (RBD) Identified by Nanobodies
por: Kaewchim, Kanasap, et al.
Publicado: (2023)

A broad and potent neutralization epitope in SARS-related coronaviruses
por: Yuan, Meng, et al.
Publicado: (2022)

A broad and potent neutralization epitope in SARS-related coronaviruses
por: Yuan, Meng, et al.
Publicado: (2022)

Potent Neutralization of SARS-CoV-2 by Hetero-Bivalent Alpaca Nanobodies Targeting the Spike Receptor-Binding Domain
por: Ma, Huan, et al.
Publicado: (2021)

Author Correction: Development of humanized tri-specific nanobodies with potent neutralization for SARS-CoV-2
por: Dong, Jianbo, et al.
Publicado: (2021)

Nanobodies Selectively Binding to the Idiotype of a Dengue Virus Neutralizing Antibody Do Not Necessarily Mimic the Viral Epitope
por: Poggianella, Monica, et al.
Publicado: (2023)

FireDock: a web server for fast interaction refinement in molecular docking(†)
por: Mashiach, Efrat, et al.
Publicado: (2008)

PharmaGist: a webserver for ligand-based pharmacophore detection
por: Schneidman-Duhovny, Dina, et al.
Publicado: (2008)

Neutralization Epitopes in Trimer and Pentamer Complexes Recognized by Potent Cytomegalovirus-Neutralizing Human Monoclonal Antibodies
por: Ai, Yuanbao, et al.
Publicado: (2022)

Multivariate mining of an alpaca immune repertoire identifies potent cross-neutralizing SARS-CoV-2 nanobodies
por: Hanke, Leo, et al.
Publicado: (2022)

Directed evolution of potent neutralizing nanobodies against SARS-CoV-2 using CDR-swapping mutagenesis
por: Zupancic, Jennifer M., et al.
Publicado: (2021)

Dynamic Evolution of the Cthrc1 Genes, a Newly Defined Collagen-Like Family
por: Leclère, Lucas, et al.
Publicado: (2020)

Nanobodies targeting conserved epitopes on the major outer membrane protein of Campylobacter as potential tools for control of Campylobacter colonization
por: Vanmarsenille, Charlotte, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_phpkiu7coou8gs0ojpc7okfrhk